15 minutes of fame in oncology
July 23rd, 2008
| Tags:
Wow, my blog on abiraterone in advanced prostate cancer got picked up last night by TopUSAsites for prostate cancer.
It looks like the drug is going to be a hot topic for a while, but caution against the hype is advised until we see whether reduction in PSA and tumour shrinkage actually translates to what really matters to patients – improved survival and better quality of life.
What say you?
Leave a comment
| Trackback

